Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.19 -0.03 (-12.41%)
At close: Oct 22, 2026 · 4:00 PM EDT

Senti Biosciences Holdings (SNTI) Total Debt (2026)

Updated

Senti Biosciences Holdings (SNTI) reported Total Debt of $3.99 million for Q2 2026.

Analysis

Senti Biosciences Holdings (SNTI) Total Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 44.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 70.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 63.19 Bn
10 Senti Biosciences Holdings 5.85 Mn -50.92 Mn - 3.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.99 Mn
API Access

Senti Biosciences Holdings Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=SNTI&period=max&api_key=YOUR_API_KEY